Home » In Focus » Big Pharma and Access to HIV/AIDS Drugs

Big Pharma and Access to HIV/AIDS Drugs


Protestors in New Delhi, India, demonstrating against the EU-India Free Trade Agreement, which would require implementing patent protection beyond typical international trade rules, 2011 © Rico Gustav, APN+

Pharmaceutical monopolies threaten access to live-saving medicines in Brazil and India

"Restriction of generic drug production in India will have a devastating public health impact around the world and adversely affect the right to health of millions of patients."
Anand Grover UN Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of health



Millions in the developing world depend on affordable generic medicines. As multinational pharmaceutical companies pursue strategies to protect patents for key drugs in India and Brazil, access to essential medicines is frustrated and concerns regarding the rising cost of life-saving drugs intensify. The situation is particularly acute for those living with HIV/AIDS in the Global South, whose lives depend on access to affordable antiretroviral medicines.


BUSINESS IMPACTS ON HUMAN RIGHTS


Fierce competition among multiple generic pharmaceutical manufacturers brought the cost of AIDS treatment down by 99 percent over the past decade. But across the globe, increased product patenting in developing countries is now threatening the production of affordable generic medicines. Challenges initiated by pharmaceutical companies in key producing countries like India and Brazil risk eliminating the kind of generic competition that helped bring prices down in the past.

Read More

DEMANDING JUSTICE


In the past decade, human rights advocates have significantly shifted government policies, corporate pricing, and even trade rules related to HIV/ AIDS medicines. Find out more Learn about the work of human rights advocates to challenging challenge multinational corporations worldwide, raising raise awareness about access to medicines, and opposing oppose patents through domestic courts.

Read More
Protestors in New Delhi, India, demonstrating against the EU-India Free Trade Agreement, which would require implementing patent protection beyond typical international trade rules, 2011 © Rico Gustav, APN+

HUMAN RIGHTS DEFENDERS


Meet the human rights defenders fighting to compel Big Pharma to lower the high cost of antiretrovirals. Learn more about the work of the Initiative for Medicines, Access & Knowledge, Conectas Direitos Humanos and others to break patent monopolies. Join them to demand justice for people living with HIV/AIDS.

Read More